CXCL12 and prostate carcinoma: Importantly, CXCL12 has been found to be expressed in many human solid tumors including breast, pancreas and prostate cancers, and glioblastoma [17], with high levels of CXCL12 expression correlating with poor prognosis of breast cancer patients [19].